Drugs Made In America Acquisition Corp.
DMAAR- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002028614
No open-market purchases or sales by Drugs Made In America Acquisition Corp. insiders were filed in the last 90 days; 28 institutions reported holding it in 13F filings for Q2 2026, worth $1.27M in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Drugs Made In America Acquisition Corp. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- +9 vs. Q2 2025
- Shares held
- 17.5M
- −148.3K (−0.8%) vs. Q2 2025
- Total value
- $3.71M
- +$1.57M (+73.6%) vs. Q2 2025
- New holders
- 12
- 2 more added
- Sold out
- 3
- 7 more reduced
1 institution that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DMAAR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 28 | $1.27M |
| Q1 2026 | 35 | $872.3K |
| Q4 2025 | 32 | $3.02M |
| Q3 2025 | 32 | $3.71M |
| Q2 2025 | 24 | $2.22M |
| Q1 2025 | 19 | $1.72M |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Drugs Made In America Acquisition Corp.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 150 | $33 | 0.00% | +150 | New |
| Readystate Asset Management LP | 50,000 | $10.9K | 0.00% | +50,000 | New |
| Periscope Capital Inc. | 75,000 | $16.3K | 0.00% | +75,000 | New |
| Parallax Volatility Advisers, L.P. | 87,926 | $19.1K | 0.00% | +87,926 | New |
| Quarry LP | 100,000 | $21.7K | 0.01% | −50,000−33.3% | Reduced |
| Verition Fund Management LLC | 100,000 | $21.8K | 0.00% | 00.0% | Unchanged |
| Bulldog Investors, LLP | 130,264 | $28.3K | 0.01% | +57,300+78.5% | Added |
| Schonfeld Strategic Advisors LLC | 147,007 | $32.0K | 0.00% | −267,485−64.5% | Reduced |
| Context Capital Management, LLC | 250,000 | $54.4K | 0.00% | +250,000 | New |
| Heights Capital Management, Inc | 289,302 | $62.9K | 0.02% | −344,514−54.4% | Reduced |
| Rivernorth Capital Management, LLC | 317,998 | $69.1K | 0.00% | +317,998 | New |
| Alpine Global Management, LLC | 362,500 | $78.8K | 0.02% | +362,500 | New |
| Whitebox Advisors LLC | 400,000 | $87.0K | 0.00% | 00.0% | Unchanged |
| LMR Partners LLP | 500,000 | $108.7K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 500,000 | $108.8K | 0.00% | 00.0% | Unchanged |
| Westchester Capital Management, LLC | 500,000 | $108.8K | 0.01% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 563,138 | $122.4K | 0.00% | −37,900−6.3% | Reduced |
| Boothbay Fund Management, LLC | 570,000 | $123.9K | 0.00% | 00.0% | Unchanged |
| Atw Spac Management LLC | 570,000 | $123.9K | 0.16% | 00.0% | Unchanged |
| Shaolin Capital Management LLC | 575,000 | $125.0K | 0.01% | +575,000 | New |
| Glazer Capital, LLC | 588,300 | $128.0K | 0.00% | −711,700−54.7% | Reduced |
| Clear Street Group Inc. | 659,093 | $143.3K | 0.00% | +659,093 | New |
| Linden Advisors LP | 850,000 | $175.2K | 0.00% | +850,000 | New |
| Mangrove Partners | 850,000 | $184.8K | 0.02% | 00.0% | Unchanged |
| Aristeia Capital LLC | 881,716 | $191.7K | 0.01% | −6,118−0.7% | Reduced |
| Highbridge Capital Management LLC | 983,600 | $213.9K | 0.01% | +133,600+15.7% | Added |
| Toronto Dominion Bank | 1,000,000 | $217.0K | 0.00% | −945,600−48.6% | Reduced |
| Harraden Circle Investments, LLC | 1,500,000 | $326.1K | 0.06% | 00.0% | Unchanged |
| Hudson Bay Capital Management LP | 1,800,000 | $391.3K | 0.00% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 1,900,000 | $412.7K | 0.01% | 00.0% | Unchanged |
| CSS LLC | 31,250 | – | – | +31,250 | New |
| Radcliffe Capital Management, L.P. | 325,100 | – | – | +325,100 | New |
| Crossingbridge Advisors, LLC | 0 | $0 | 0.00% | −850,000−100.0% | Sold out |
| Cantor Fitzgerald, L. P. | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Mizuho Securities USA LLC | 0 | $0 | 0.00% | −209,897−100.0% | Sold out |
| Clear Street LLC | – | – | – | – | Not filed |